2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
B

ASCO 2020 Updates on mCRPC: 177Lu-PSMA-617 Theranostic vs. Cabazitaxel - What Are the PSA Response Rate Differences?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Bruno Bastos
By 2020 ASCO Virtual Direct™ Highlights FEATURING Bruno Bastos
16 views
September 29, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
GU
13:03
2020 ASCO Virtual Direct™ Highlights

ASCO 2020 Highlights on PC: 18F-DCFPyL-PET/CT and Clinical Impact on…

Feat. B. Bastos
07:42
2020 ASCO Virtual Direct™ Highlights

ASCO 2020 Updates on mCRPC: 177Lu-PSMA-617 Theranostic vs. Cabazitax…

Feat. B. Bastos
10:46
2020 ASCO Virtual Direct™ Highlights

ASCO 2020 Updates on Advanced PC: Relugolix vs. Leuprolide Acetate i…

Feat. B. Bastos
05:54
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on High-Risk MIBC: Can We Improve DFS/OS With Adju…

Feat. W. Tan
12:52
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Advanced RCC: Pembro+Axitinib vs. Sunitinib …

Feat. W. Tan
05:17
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Advanced UC: How Does Maintenance Avelumab + BS…

Feat. W. Tan